Intellia Therapeutics Inc (NASDAQ:NTLA)

88.12
Delayed Data
As of Jun 14
 +2.71 / +3.18%
Today’s Change
16.54
Today|||52-Week Range
92.00
+61.99%
Year-to-Date
CRISPR (CRSP) Up on Positive New Gene Therapy CTX001 Data
Jun 14 / Zacks.com - Paid Partner Content
What's the Best Way to Invest in Genetics Stocks?
Jun 07 / MotleyFool.com - Paid Partner Content
3 Biotech ETFs That Could Double Your Money by 2025 With Zero Effort
Jun 13 / MotleyFool.com - Paid Partner Content
This Genetics Stock Could Have a Bright Future
Jun 03 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close85.29
Today’s open84.21
Day’s range84.21 - 89.26
Volume1,740,890
Average volume (3 months)1,339,117
Market cap$5.8B
Data as of 4:00pm ET, 06/14/2021

Growth & Valuation

Earnings growth (last year)-13.81%
Earnings growth (this year)-9.14%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)+34.55%
P/E ratioNM
Price/Sales52.52
Price/Book10.72

Competitors

----
----
KODKodiak Sciences Inc+1.25+1.49%
TWSTTwist Bioscience Cor...-1.86-1.62%
Data as of 3:59pm ET, 06/14/2021

Financials

Next reporting dateAugust 5, 2021
EPS forecast (this quarter)-$0.62
Annual revenue (last year)$58.0M
Annual profit (last year)-$134.2M
Net profit margin-231.46%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts